Library Subscription: Guest
Critical Reviews™ in Immunology

Published 6 issues per year

ISSN Print: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Antigen Delivery to Plasmacytoid Dendritic Cells -Induction of Tolerance and Immunity

Volume 32, Issue 6, 2012, pp. 489-501
DOI: 10.1615/CritRevImmunol.v32.i6.20
Get accessGet access

ABSTRACT

Dendritic cells are professional antigen presenting cells linking the innate and the adaptive immune system. Antibody mediated antigen delivery to functionally distinct DC subpopulations is a promising approach to induce or inhibit antigen specific immune responses in vivo and is useful for designing therapeutic vaccination strategies. This review focuses on the state of the art of this technique and describes recent findings of antigen targeting to the subpopulation of plasmacytoid dendritic cells and the possibilities to induce immunity or attenuate autoimmunity by delivering antigens specifically to this cell type.

CITED BY
  1. Chappell Craig P., Giltiay Natalia V., Dresch Christiane, Clark Edward A., Controlling immune responses by targeting antigens to dendritic cell subsets and B cells, International Immunology, 26, 1, 2014. Crossref

  2. Dillon Patrick M., Slingluff Craig L., Peptide Vaccine: Overview, in Cancer Therapeutic Targets, 2017. Crossref

  3. Chappell Craig P., Giltiay Natalia V., Draves Kevin E., Chen ChangHung, Hayden-Ledbetter Martha S., Shlomchik Mark J., Kaplan Daniel H., Clark Edward A., Targeting Antigens through Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells Promotes Immunologic Tolerance, The Journal of Immunology, 192, 12, 2014. Crossref

  4. Dillon Patrick M., Slingluff Craig L., Peptide Vaccine: Overview, in Cancer Therapeutic Targets, 2015. Crossref

  5. Biessen Erik A.L., Christ Anette, Plasmacytoid Dendritic Cells in Atherosclerosis, Circulation, 130, 16, 2014. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain